JP2006517557A5 - - Google Patents

Download PDF

Info

Publication number
JP2006517557A5
JP2006517557A5 JP2006501788A JP2006501788A JP2006517557A5 JP 2006517557 A5 JP2006517557 A5 JP 2006517557A5 JP 2006501788 A JP2006501788 A JP 2006501788A JP 2006501788 A JP2006501788 A JP 2006501788A JP 2006517557 A5 JP2006517557 A5 JP 2006517557A5
Authority
JP
Japan
Prior art keywords
stroke
angiotensin
antagonist
pharmaceutical composition
telmisartan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006501788A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006517557A (ja
Filing date
Publication date
Priority claimed from DE10306179A external-priority patent/DE10306179A1/de
Application filed filed Critical
Publication of JP2006517557A publication Critical patent/JP2006517557A/ja
Publication of JP2006517557A5 publication Critical patent/JP2006517557A5/ja
Pending legal-status Critical Current

Links

JP2006501788A 2003-02-13 2004-02-10 脳卒中発作予防のための、アセチルサリチル酸およびアンジオテンシンｉｉ拮抗薬と組み合わせたジピリダモールの使用 Pending JP2006517557A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10306179A DE10306179A1 (de) 2003-02-13 2003-02-13 Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
EP03018212 2003-08-08
PCT/EP2004/001208 WO2004071385A2 (en) 2003-02-13 2004-02-10 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention

Publications (2)

Publication Number Publication Date
JP2006517557A JP2006517557A (ja) 2006-07-27
JP2006517557A5 true JP2006517557A5 (enExample) 2007-03-29

Family

ID=32870338

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006501788A Pending JP2006517557A (ja) 2003-02-13 2004-02-10 脳卒中発作予防のための、アセチルサリチル酸およびアンジオテンシンｉｉ拮抗薬と組み合わせたジピリダモールの使用

Country Status (29)

Country Link
US (5) US20040214802A1 (enExample)
EP (2) EP1733729A1 (enExample)
JP (1) JP2006517557A (enExample)
KR (1) KR20050100676A (enExample)
CN (1) CN1750830A (enExample)
AR (1) AR043173A1 (enExample)
AT (1) ATE395921T1 (enExample)
AU (1) AU2004212305A1 (enExample)
BR (1) BRPI0407457A (enExample)
CA (1) CA2515941A1 (enExample)
DE (2) DE10306179A1 (enExample)
DK (1) DK1603573T3 (enExample)
EA (1) EA200501231A1 (enExample)
EC (1) ECSP055963A (enExample)
ES (1) ES2308147T3 (enExample)
HR (1) HRP20050713A2 (enExample)
MX (1) MXPA05008572A (enExample)
NO (1) NO20054216L (enExample)
NZ (1) NZ542302A (enExample)
PE (1) PE20050191A1 (enExample)
PL (1) PL378204A1 (enExample)
PT (1) PT1603573E (enExample)
RS (1) RS20050618A (enExample)
SI (1) SI1603573T1 (enExample)
TW (1) TW200501957A (enExample)
UA (1) UA83481C2 (enExample)
UY (1) UY28182A1 (enExample)
WO (1) WO2004071385A2 (enExample)
ZA (1) ZA200505956B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10335027A1 (de) * 2003-07-31 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Angiotensin II Rezeptor Antagonisten
DE10306179A1 (de) * 2003-02-13 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
CA2437709A1 (en) * 2003-08-08 2005-02-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of dipyridamole, acetylsalicylic acid and an angiotensin ii antagonist for treatment and prevention of vascular events
JP2005060359A (ja) * 2003-08-13 2005-03-10 Boehringer Ingelheim Pharma Gmbh & Co Kg 血管系病態の治療及び予防のためのジピリダモール、アセチルサリチル酸及びアンギオテンシンｉｉ拮抗薬の使用
WO2009080301A1 (en) * 2007-12-21 2009-07-02 Boehringer Ingelheim International Gmbh Treatment and prevention of ischaemic cerebral lesions and cerebrovascular cognitive impairment using a treatment regimen consisting of dipyridamole and an angiotensin ii receptor blocker in patients with previous stroke
WO2009100534A1 (en) * 2008-02-14 2009-08-20 Kardiatech, Inc. Combination therapy to treat vascular disorders
US20100069326A1 (en) * 2008-02-14 2010-03-18 Wasimul Haque Combination Therapies to Treat Cardio- and Cerebro-Vascular Disorders
WO2010097501A2 (en) * 2009-02-26 2010-09-02 Orion Corporation A combination treatment
US8633158B1 (en) * 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
TWI725008B (zh) * 2015-01-28 2021-04-21 瑞采生技有限公司 用於增強ＰＰＡＲγ表現及核轉位之化合物及其醫療用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3031458A (en) * 1958-02-05 1962-04-24 Ciba Pharm Prod Inc Isoindolines
US3031450A (en) 1959-04-30 1962-04-24 Thomae Gmbh Dr K Substituted pyrimido-[5, 4-d]-pyrimidines
US3317279A (en) * 1963-03-15 1967-05-02 Pennsalt Chemicals Corp Polymorph of calcium disilicide and its method of preparation
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
DE3000979A1 (de) 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
US4318477A (en) * 1980-09-22 1982-03-09 Kerpe Stase Z Pharmaceutical package
DE3124090A1 (de) 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
DE3627423A1 (de) 1986-08-13 1988-02-18 Thomae Gmbh Dr K Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
CA1338238C (en) 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
US5015651A (en) 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
SI9210098B (sl) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
EP1013273A1 (en) 1998-12-23 2000-06-28 Novartis AG Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
EP1093814A1 (en) * 1999-10-22 2001-04-25 Boehringer Ingelheim Pharma KG Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
JP2002138054A (ja) * 2000-08-25 2002-05-14 Takeda Chem Ind Ltd フィブリノーゲン低下剤
JP2002293742A (ja) * 2001-01-29 2002-10-09 Takeda Chem Ind Ltd 鎮痛・抗炎症剤
JP2003212758A (ja) * 2001-03-16 2003-07-30 Takeda Chem Ind Ltd 徐放性製剤の製造法
DE10306179A1 (de) * 2003-02-13 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe

Similar Documents

Publication Publication Date Title
FI3457135T3 (fi) Fabryn taudin hoitovaihtoehtoja
JP2012515184A5 (enExample)
JP2013542247A5 (enExample)
HRP20200600T1 (hr) Tapentadol za sprječavanje i liječenje depresije i tjeskobe
ES2553742T3 (es) Forma de dosificación farmacéutica que comprende 6'-fluor-(N-metil- o N,N-dimetil)-4-fenil-4',9'-dihidro-3'H-espiro[ciclohexano-1,1'-pirano[3,4,b]indol]-4-amina
JP2005512995A5 (enExample)
WO2009104932A3 (ko) 복합제제
HRP20160119T1 (hr) Inhibitor benzodiazepinske bromodomene
JP2010525050A5 (enExample)
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
JP2012255026A5 (enExample)
FI3494972T3 (fi) Dolutegraviirin ja lamivudiinin yhdistelmiä hiv-infektion hoitoon
HRP20131120T1 (hr) Farmaceutski pripravak koji sadrži (1s)-1,5-anhidro-1-[5-(4-etoksibenzil)-2-metoksi-4-metilfenil]-1-tio-d-glucitol i metformin, te njegova uporaba za lijeäśenje dijabetesa
JP2010535814A5 (enExample)
RU2016133305A (ru) Состав с длительным высвобождением для снижения частоты мочеиспускания и способ его применения
WO2007123865A3 (en) Treatment of inflammatory and ulcerative diseases of the bowel with opioid antagonists
JP2009537554A5 (enExample)
JP2006517557A5 (enExample)
JP2015510928A5 (enExample)
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
MX2010007281A (es) Composiciones farmaceuticas de amlodipina y valsartan.
HRP20171742T4 (hr) 2,4,6-trifluor-n-[6-(1-metilpiperidin-4-karbonil)piridin-2-il]benzamid, namijenjen liječenju migrene oralnom ili intravenskom primjenom
JP2007238598A5 (enExample)
WO2007145863A3 (en) Sustained release formulation of naltrexone
JP2009522376A5 (enExample)